SCHOTT PHARMA AG & CO. KGAA financial statements, including revenue, expenses, profit, and loss
The total revenue of 1SXP for the last quarter is 232.00 M EUR, and it's 1.52% higher compared to the previous quarter. The net income of Q1 24 is 45.00 M EUR.